Filters

Pp-207 manufacturers

Filters

None products found

pp-207

Cream

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Indication: Erythromelalgia — rare painful peripheral vascular disorder causing severe burning pain in extremities Clinical stage: Phase 2 data positive; FDA-guided development into Phase 2/3 Modality: Small molecule (TRPV1 receptor antagonist) Mechanism / Target: Topical TRPV1 (transient receptor potential vanilloid type 1) receptor antagonist; blocks peripheral nociceptor heat-pain signalling at the site of erythromelalgia; topical delivery avoids systemic hyperthermia associated with oral TRPV1 blockers Route / form: Topical cream/gel (applied to affected extremities) Differentiation: First TRPV1 antagonist in development for erythromelalgia; topical formulation uniquely avoids systemic TRPV1 side effects (hyperthermia/reduced body temperature regulation);
Manufacturer #39344
Europe-based publicly listed pharmaceutical company developing Rx small-molecule treatments for CNS disorders, including Alzheimer's disease and pain. Multiple oral candidates advance through proprietary research platforms at clinical and preclinical stages.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.